Division of General Pediatrics, Medical University of South Carolina, Charleston, SC 29425, USA.
J Pediatr. 2012 Feb;160(2):325-30. doi: 10.1016/j.jpeds.2011.07.037. Epub 2011 Aug 31.
To determine what proportion of patients who are seen in an emergency department (ED) for asthma receive inhaled corticosteroids or attend follow-up appointments.
This was a retrospective cohort study of 2007-2009 South Carolina Medicaid data. Enrollees aged 2-18 years who had an ED visit for asthma were included. Patients admitted for asthma or with an inhaled corticosteroid claim in the 2 months before the month of the ED visit were excluded. Covariates were sex, race, age, rural residence, and asthma severity. Outcome measures were a prescription for an inhaled corticosteroid filled within the 2 months after the ED visit and attendance at a follow-up appointment within the 2 months after the ED visit.
A total of 3435 patients were included. Out of the study cohort, 57% were male, 76% were of a minority race/ethnicity, 69% lived in an urban areas, 18% had inhaled corticosteroid use, and 12% completed follow-up. Multivariate analyses demonstrated that patients with severe asthma were more likely to receive an inhaled corticosteroid (OR, 2.9; 95% CI, 2.3-3.7) and attend a follow-up appointment (OR, 2.0; 95% CI, 1.5-2.6). Patients aged 2-6 years and those aged >12 years were less likely to attend follow-up (OR, 0.71; 95% CI, 0.56-0.90 and OR, 0.62; 95% CI, 0.47-0.83, respectively) (all models P < .0001).
Children with asthma seen in the ED have low rates of inhaled corticosteroid use and outpatient follow-up. This indicates a need for further interventions to increase the use of inhaled corticosteroids in response to ED visits.
确定在急诊科(ED)就诊的哮喘患者中有多大比例接受吸入皮质类固醇或进行随访预约。
这是一项对 2007 年至 2009 年南卡罗来纳州医疗补助数据的回顾性队列研究。纳入年龄在 2-18 岁之间因哮喘就诊 ED 的参保人。排除因哮喘住院或在 ED 就诊前 2 个月内有吸入皮质类固醇报销的患者。协变量为性别、种族、年龄、农村居住和哮喘严重程度。主要结局为 ED 就诊后 2 个月内开具的吸入皮质类固醇处方和 ED 就诊后 2 个月内进行的随访预约。
共纳入 3435 例患者。研究队列中,57%为男性,76%为少数民族/族裔,69%居住在城市地区,18%使用过吸入皮质类固醇,12%完成了随访。多变量分析表明,哮喘严重程度高的患者更有可能接受吸入皮质类固醇治疗(OR,2.9;95%CI,2.3-3.7)和进行随访预约(OR,2.0;95%CI,1.5-2.6)。2-6 岁和>12 岁的患者不太可能进行随访(OR,0.71;95%CI,0.56-0.90 和 OR,0.62;95%CI,0.47-0.83,均 P<0.0001)(所有模型)。
在 ED 就诊的哮喘儿童吸入皮质类固醇使用率和门诊随访率较低。这表明需要进一步干预,以增加因 ED 就诊而使用吸入皮质类固醇的情况。